MGLL and depressive symptom measurement: The therapeutic potential of MGL inhibitors for the treatment of pain and inflammation, depression, nausea, neurodegeneration, precipitated opioid or cannabis withdrawal responses, and cancer pathogenicity, due to MGL blockade, has been investigated11–19.